Skip to main content
Erschienen in: Urolithiasis 4/2016

22.03.2016 | Invited Review

Ascorbic acid intake and oxalate synthesis

verfasst von: John Knight, Kumudu Madduma-Liyanage, James A. Mobley, Dean G. Assimos, Ross P. Holmes

Erschienen in: Urolithiasis | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

In humans, approximately 60 mg of ascorbic acid (AA) breaks down in the body each day and has to be replaced by a dietary intake of 70 mg in women and 90 mg in men to maintain optimal health and AA homeostasis. The breakdown of AA is non-enzymatic and results in oxalate formation. The exact amount of oxalate formed has been difficult to ascertain primarily due to the limited availability of healthy human tissue for such research and the difficulty in measuring AA and its breakdown products. The breakdown of 60 mg of AA to oxalate could potentially result in the formation of up to 30 mg oxalate per day. This exceeds our estimates of the endogenous production of 10–25 mg oxalate per day, indicating that degradative pathways that do not form oxalate exist. In this review, we examine what is known about the pathways of AA metabolism and how oxalate forms. We further identify how gaps in our knowledge may be filled to more precisely determine the contribution of AA breakdown to oxalate production in humans. The use of stable isotopes of AA to directly assess the conversion of vitamin to oxalate should help fill this void.
Literatur
1.
Zurück zum Zitat Hellman L, Burns JJ (1958) Metabolism of l-ascorbic acid-1-C14 in man. J Biol Chem 230:923–930PubMed Hellman L, Burns JJ (1958) Metabolism of l-ascorbic acid-1-C14 in man. J Biol Chem 230:923–930PubMed
2.
Zurück zum Zitat Atkins GL, Dean BM, Griffin WJ, Watts RWE (1964) Quantitative aspects of ascorbic acid metabolism in man. J Biol Chem 239:2975–2980PubMed Atkins GL, Dean BM, Griffin WJ, Watts RWE (1964) Quantitative aspects of ascorbic acid metabolism in man. J Biol Chem 239:2975–2980PubMed
3.
Zurück zum Zitat Baker EM, Saari JC, Tolbert BM (1966) Ascorbic acid metabolism in man. Amer J Clin Nutr 19:371–378PubMed Baker EM, Saari JC, Tolbert BM (1966) Ascorbic acid metabolism in man. Amer J Clin Nutr 19:371–378PubMed
4.
Zurück zum Zitat Chalmers AH, Cowley DM (1985) Stability of ascorbate in urine: relevance to analyses for ascorbate and oxalate. Clin Chem 31:1703–1705PubMed Chalmers AH, Cowley DM (1985) Stability of ascorbate in urine: relevance to analyses for ascorbate and oxalate. Clin Chem 31:1703–1705PubMed
5.
Zurück zum Zitat Mazzachi BC, Teubner JK, Ryall RL (1984) Factors affecting measurement of urinary oxalate. Clin Chem 30:1339–1343PubMed Mazzachi BC, Teubner JK, Ryall RL (1984) Factors affecting measurement of urinary oxalate. Clin Chem 30:1339–1343PubMed
6.
Zurück zum Zitat Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol JASN 15:3225–3232CrossRefPubMed Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol JASN 15:3225–3232CrossRefPubMed
7.
Zurück zum Zitat Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A (2013) Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med 173:386–388CrossRefPubMed Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A (2013) Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med 173:386–388CrossRefPubMed
8.
Zurück zum Zitat Lawton JM, Conway LT, Crosson JT, Smith CL, Abraham PA (1985) Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med 145:950–951CrossRefPubMed Lawton JM, Conway LT, Crosson JT, Smith CL, Abraham PA (1985) Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med 145:950–951CrossRefPubMed
10.
Zurück zum Zitat Nasr SH, Kashtanova Y, Levchuk V, Markowitz GS (2006) Secondary oxalosis due to excess vitamin C intake. Kidney Int 70:1672CrossRefPubMed Nasr SH, Kashtanova Y, Levchuk V, Markowitz GS (2006) Secondary oxalosis due to excess vitamin C intake. Kidney Int 70:1672CrossRefPubMed
11.
Zurück zum Zitat Mashour S, Turner JF Jr, Merrell R (2000) Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature. Chest 118:561–563CrossRefPubMed Mashour S, Turner JF Jr, Merrell R (2000) Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature. Chest 118:561–563CrossRefPubMed
12.
Zurück zum Zitat Alkhunaizi AM, Chan L (1996) Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure. J Am Soc Nephrol: JASN 7:2320–2326PubMed Alkhunaizi AM, Chan L (1996) Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure. J Am Soc Nephrol: JASN 7:2320–2326PubMed
13.
Zurück zum Zitat Robitaille L, Mamer OA, Miller WH Jr, Levine M, Assouline S, Melnychuk D, Rousseau C, Hoffer LJ (2009) Oxalic acid excretion after intravenous ascorbic acid administration. Metab Clin Exp 58:263–269CrossRefPubMedPubMedCentral Robitaille L, Mamer OA, Miller WH Jr, Levine M, Assouline S, Melnychuk D, Rousseau C, Hoffer LJ (2009) Oxalic acid excretion after intravenous ascorbic acid administration. Metab Clin Exp 58:263–269CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Nishikimi M, Yagi K (1991) Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. Am J Clin Nutr 54:1203S–1208SPubMed Nishikimi M, Yagi K (1991) Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. Am J Clin Nutr 54:1203S–1208SPubMed
17.
Zurück zum Zitat Grano A, De Tullio MC (2007) Ascorbic acid as a sensor of oxidative stress and a regulator of gene expression: the Yin and Yang of vitamin C. Med Hypotheses 69:953–954CrossRefPubMed Grano A, De Tullio MC (2007) Ascorbic acid as a sensor of oxidative stress and a regulator of gene expression: the Yin and Yang of vitamin C. Med Hypotheses 69:953–954CrossRefPubMed
18.
Zurück zum Zitat Du J, Cullen JJ, Buettner GR (2012) Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta 1826:443–457PubMedPubMedCentral Du J, Cullen JJ, Buettner GR (2012) Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta 1826:443–457PubMedPubMedCentral
19.
Zurück zum Zitat Linster CL, Van Schaftingen E (2007) Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J 274:1–22CrossRefPubMed Linster CL, Van Schaftingen E (2007) Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J 274:1–22CrossRefPubMed
20.
Zurück zum Zitat Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270–276CrossRefPubMed Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270–276CrossRefPubMed
21.
Zurück zum Zitat Knight J, Assimos DG, Callahan MF, Holmes RP (2011) Metabolism of primed, constant infusions of [1,2-(13)C(2)] glycine and [1-(13)C(1)] phenylalanine to urinary oxalate. Metab Clin Exp 60:950–956CrossRefPubMed Knight J, Assimos DG, Callahan MF, Holmes RP (2011) Metabolism of primed, constant infusions of [1,2-(13)C(2)] glycine and [1-(13)C(1)] phenylalanine to urinary oxalate. Metab Clin Exp 60:950–956CrossRefPubMed
22.
23.
Zurück zum Zitat Holmes RP, Kennedy M (2000) Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int 57:1662–1667CrossRefPubMed Holmes RP, Kennedy M (2000) Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int 57:1662–1667CrossRefPubMed
24.
Zurück zum Zitat von Unruh GE, Voss S, Sauerbruch T, Hesse A (2003) Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2] oxalate absorption test. J Urol 169:687–690CrossRef von Unruh GE, Voss S, Sauerbruch T, Hesse A (2003) Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2] oxalate absorption test. J Urol 169:687–690CrossRef
25.
Zurück zum Zitat Fan X, Sokorai KJ (2011) Changes in quality, liking, and purchase intent of irradiated fresh-cut spinach during storage. J Food Sci 76:S363–S368CrossRefPubMed Fan X, Sokorai KJ (2011) Changes in quality, liking, and purchase intent of irradiated fresh-cut spinach during storage. J Food Sci 76:S363–S368CrossRefPubMed
26.
Zurück zum Zitat Jansson PJ, Jung HR, Lindqvist C, Nordstrom T (2004) Oxidative decomposition of vitamin C in drinking water. Free Radical Res 38:855–860CrossRef Jansson PJ, Jung HR, Lindqvist C, Nordstrom T (2004) Oxidative decomposition of vitamin C in drinking water. Free Radical Res 38:855–860CrossRef
27.
Zurück zum Zitat Burzle M, Suzuki Y, Ackermann D, Miyazaki H, Maeda N, Clemencon B, Burrier R, Hediger MA (2013) The sodium-dependent ascorbic acid transporter family SLC23. Mol Asp Med 34:436–454CrossRef Burzle M, Suzuki Y, Ackermann D, Miyazaki H, Maeda N, Clemencon B, Burrier R, Hediger MA (2013) The sodium-dependent ascorbic acid transporter family SLC23. Mol Asp Med 34:436–454CrossRef
28.
Zurück zum Zitat Corpe CP, Eck P, Wang J, Al-Hasani H, Levine M (2013) Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8. J Biol Chem 288:9092–9101CrossRefPubMedPubMedCentral Corpe CP, Eck P, Wang J, Al-Hasani H, Levine M (2013) Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8. J Biol Chem 288:9092–9101CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Kallner A, Hartmann D, Hornig D (1977) On the absorption of ascorbic acid in man. Int J Vitam Nutr Res. Int Z fur Vitam und Ernahrungsforschung. J Int de Vitaminol et de Nutr 47:383–388 Kallner A, Hartmann D, Hornig D (1977) On the absorption of ascorbic acid in man. Int J Vitam Nutr Res. Int Z fur Vitam und Ernahrungsforschung. J Int de Vitaminol et de Nutr 47:383–388
30.
Zurück zum Zitat Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazerev A, Graumlich JF, King J, Cantilena LR (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci 93:3704–3709CrossRefPubMedPubMedCentral Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazerev A, Graumlich JF, King J, Cantilena LR (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci 93:3704–3709CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Bluck LJ, Izzard AP, Bates CJ (1996) Measurement of ascorbic acid kinetics in man using stable isotopes and gas chromatography/mass spectrometry. J Mass Spectrom: JMS 31:741–748CrossRefPubMed Bluck LJ, Izzard AP, Bates CJ (1996) Measurement of ascorbic acid kinetics in man using stable isotopes and gas chromatography/mass spectrometry. J Mass Spectrom: JMS 31:741–748CrossRefPubMed
32.
Zurück zum Zitat Kallner A, Hartmann D, Hornig D (1979) Steady-state turnover and body pool of ascorbic acid in man. Am J Clin Nutr 32:530–539PubMed Kallner A, Hartmann D, Hornig D (1979) Steady-state turnover and body pool of ascorbic acid in man. Am J Clin Nutr 32:530–539PubMed
33.
Zurück zum Zitat Omaye ST, Schaus EE, Kutnink MA, Hawkes WC (1987) Measurement of vitamin C in blood components by high-performance liquid chromatography. Implication in assessing vitamin C status. Ann New York Acad Sci 498:389–401CrossRef Omaye ST, Schaus EE, Kutnink MA, Hawkes WC (1987) Measurement of vitamin C in blood components by high-performance liquid chromatography. Implication in assessing vitamin C status. Ann New York Acad Sci 498:389–401CrossRef
34.
Zurück zum Zitat Levine M, Wang Y, Padayatty SJ, Morrow J (2001) A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 98:9842–9846CrossRefPubMedPubMedCentral Levine M, Wang Y, Padayatty SJ, Morrow J (2001) A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 98:9842–9846CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Baker PR, Cramer SD, Kennedy M, Assimos DG, Holmes RP (2004) Glycolate and glyoxylate metabolism in HepG2 cells. Amer J Physiol 287:C1359–C1365CrossRef Baker PR, Cramer SD, Kennedy M, Assimos DG, Holmes RP (2004) Glycolate and glyoxylate metabolism in HepG2 cells. Amer J Physiol 287:C1359–C1365CrossRef
36.
Zurück zum Zitat Knight J, Holmes RP, Cramer SD, Takayama T, Salido E (2012) Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol. Renal Physiol 302:F688–F693CrossRefPubMed Knight J, Holmes RP, Cramer SD, Takayama T, Salido E (2012) Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol. Renal Physiol 302:F688–F693CrossRefPubMed
37.
Zurück zum Zitat Corti A, Casini AF, Pompella A (2010) Cellular pathways for transport and efflux of ascorbate and dehydroascorbate. Arch Biochem Biophys 500:107–115CrossRefPubMed Corti A, Casini AF, Pompella A (2010) Cellular pathways for transport and efflux of ascorbate and dehydroascorbate. Arch Biochem Biophys 500:107–115CrossRefPubMed
38.
Zurück zum Zitat Rumsy SC, Levine M (1998) Absorption, transport, and disposition of ascorbic acid in humans. Nutr Biochem 9:116–130CrossRef Rumsy SC, Levine M (1998) Absorption, transport, and disposition of ascorbic acid in humans. Nutr Biochem 9:116–130CrossRef
39.
Zurück zum Zitat Levine M, Padayatty SJ, Espey MG (2011) Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr 2:78–88CrossRefPubMedPubMedCentral Levine M, Padayatty SJ, Espey MG (2011) Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr 2:78–88CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Stephenson CM, Levin RD, Spector T, Lis CG (2013) Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol 72:139–146CrossRefPubMedPubMedCentral Stephenson CM, Levin RD, Spector T, Lis CG (2013) Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol 72:139–146CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, Muley A, Asara JM, Paik J, Elemento O, Chen Z, Pappin DJ, Dow LE, Papadopoulos N, Gross SS, Cantley LC (2015) Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350:1391–1396CrossRefPubMed Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, Muley A, Asara JM, Paik J, Elemento O, Chen Z, Pappin DJ, Dow LE, Papadopoulos N, Gross SS, Cantley LC (2015) Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350:1391–1396CrossRefPubMed
42.
Zurück zum Zitat Park JB, Levine M (1996) Purification, cloning and expression of dehydroascorbic acid-reducing activity from human neutrophils: identification as glutaredoxin. Biochem J 315(Pt 3):931–938CrossRefPubMedPubMedCentral Park JB, Levine M (1996) Purification, cloning and expression of dehydroascorbic acid-reducing activity from human neutrophils: identification as glutaredoxin. Biochem J 315(Pt 3):931–938CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Simpson GL, Ortwerth BJ (2000) The non-oxidative degradation of ascorbic acid at physiological conditions. Biochim Biophys Acta 1501:12–24CrossRefPubMed Simpson GL, Ortwerth BJ (2000) The non-oxidative degradation of ascorbic acid at physiological conditions. Biochim Biophys Acta 1501:12–24CrossRefPubMed
45.
Zurück zum Zitat Gál I (1936) Estimation of ascorbic acid (vitamin C) by titration. Nature 138:799CrossRef Gál I (1936) Estimation of ascorbic acid (vitamin C) by titration. Nature 138:799CrossRef
46.
Zurück zum Zitat Moeslinger T, Brunner M, Volf I, Spieckermann PG (1995) Spectrophotometric determination of ascorbic acid and dehydroascorbic acid. Clin Chem 41:1177–1181PubMed Moeslinger T, Brunner M, Volf I, Spieckermann PG (1995) Spectrophotometric determination of ascorbic acid and dehydroascorbic acid. Clin Chem 41:1177–1181PubMed
47.
Zurück zum Zitat Lee W, Roberts SM, Labbe RF (1997) Ascorbic acid determination with an automated enzymatic procedure. Clin Chem 43:154–157PubMed Lee W, Roberts SM, Labbe RF (1997) Ascorbic acid determination with an automated enzymatic procedure. Clin Chem 43:154–157PubMed
48.
Zurück zum Zitat Lykkesfeldt J (2007) Ascorbate and dehydroascorbic acid as reliable biomarkers of oxidative stress: analytical reproducibility and long-term stability of plasma samples subjected to acidic deproteinization. Cancer Epidemiol Biomark Prev 16:2513–2516CrossRef Lykkesfeldt J (2007) Ascorbate and dehydroascorbic acid as reliable biomarkers of oxidative stress: analytical reproducibility and long-term stability of plasma samples subjected to acidic deproteinization. Cancer Epidemiol Biomark Prev 16:2513–2516CrossRef
49.
Zurück zum Zitat Chen Z, Chen B, Yao S (2006) High-performance liquid chromatography/electrospray ionization-mass spectrometry for simultaneous determination of taurine and 10 water-soluble vitamins in multivitamin tablets. Anal Chim Acta 569:169–175CrossRef Chen Z, Chen B, Yao S (2006) High-performance liquid chromatography/electrospray ionization-mass spectrometry for simultaneous determination of taurine and 10 water-soluble vitamins in multivitamin tablets. Anal Chim Acta 569:169–175CrossRef
50.
Zurück zum Zitat Shui G, Leong LP (2004) Analysis of polyphenolic antioxidants in star fruit using liquid chromatography and mass spectrometry. J Chromatogr A 1022:67–75CrossRefPubMed Shui G, Leong LP (2004) Analysis of polyphenolic antioxidants in star fruit using liquid chromatography and mass spectrometry. J Chromatogr A 1022:67–75CrossRefPubMed
51.
Zurück zum Zitat Szultka M, Buszewska-Forajta M, Kaliszan R, Buszewski B (2014) Determination of ascorbic acid and its degradation products by high-performance liquid chromatography-triple quadrupole mass spectrometry. Electrophoresis 35:585–592CrossRefPubMed Szultka M, Buszewska-Forajta M, Kaliszan R, Buszewski B (2014) Determination of ascorbic acid and its degradation products by high-performance liquid chromatography-triple quadrupole mass spectrometry. Electrophoresis 35:585–592CrossRefPubMed
52.
Zurück zum Zitat Fenoll J, Martinez A, Hellin P, Flores P (2011) Simultaneous determination of ascorbic and dehydroascorbic acids in vegetables and fruits by liquid chromatography with tandem mass spectrometry. Food Chem 127:340–344CrossRef Fenoll J, Martinez A, Hellin P, Flores P (2011) Simultaneous determination of ascorbic and dehydroascorbic acids in vegetables and fruits by liquid chromatography with tandem mass spectrometry. Food Chem 127:340–344CrossRef
53.
Zurück zum Zitat Wang H, Jiang J, Hu P (2006) Determination of l-threonate in human plasma and urine by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr. B Anal Technol Biomed Life Sci 834:155–162CrossRef Wang H, Jiang J, Hu P (2006) Determination of l-threonate in human plasma and urine by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr. B Anal Technol Biomed Life Sci 834:155–162CrossRef
54.
Zurück zum Zitat Deutsch JC (1998) Spontaneous hydrolysis and dehydration of dehydroascorbic acid in aqueous solution. Anal Biochem 260:223–229CrossRefPubMed Deutsch JC (1998) Spontaneous hydrolysis and dehydration of dehydroascorbic acid in aqueous solution. Anal Biochem 260:223–229CrossRefPubMed
55.
Zurück zum Zitat Traxer O, Huet B, Poindexter J, Pak CY, Pearle MS (2003) Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 170:397–401CrossRefPubMed Traxer O, Huet B, Poindexter J, Pak CY, Pearle MS (2003) Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 170:397–401CrossRefPubMed
56.
Zurück zum Zitat Baxmann AC, De OGMC, Heilberg IP (2003) Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int 63:1066–1071CrossRefPubMed Baxmann AC, De OGMC, Heilberg IP (2003) Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int 63:1066–1071CrossRefPubMed
57.
Zurück zum Zitat Khan SR (2012) Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res 40:95–112CrossRefPubMed Khan SR (2012) Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res 40:95–112CrossRefPubMed
58.
Zurück zum Zitat Ribeiro DO, Pinto DC, Lima LM, Volpato NM, Cabral LM, de Sousa VP (2011) Chemical stability study of vitamins thiamine, riboflavin, pyridoxine and ascorbic acid in parenteral nutrition for neonatal use. Nutr J 10:47CrossRefPubMedPubMedCentral Ribeiro DO, Pinto DC, Lima LM, Volpato NM, Cabral LM, de Sousa VP (2011) Chemical stability study of vitamins thiamine, riboflavin, pyridoxine and ascorbic acid in parenteral nutrition for neonatal use. Nutr J 10:47CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Holmes RP, Goodman HO, Assimos DG (1995) Dietary oxalate and its intestinal absorption. Scan Microsc 9:1109–1120 Holmes RP, Goodman HO, Assimos DG (1995) Dietary oxalate and its intestinal absorption. Scan Microsc 9:1109–1120
60.
Zurück zum Zitat Pena de la Vega L, Lieske JC, Milliner D, Gonyea J, Kelly DG (2004) Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose. JPEN J Parenter Enter Nutr 28:435–438CrossRef Pena de la Vega L, Lieske JC, Milliner D, Gonyea J, Kelly DG (2004) Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose. JPEN J Parenter Enter Nutr 28:435–438CrossRef
62.
Zurück zum Zitat Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M (2010) Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 5:e11414CrossRefPubMedPubMedCentral Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M (2010) Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 5:e11414CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Cossey LN, Rahim F, Larsen CP (2013) Oxalate nephropathy and intravenous vitamin C. Am J Kidney Dis 61:1032–1035CrossRefPubMed Cossey LN, Rahim F, Larsen CP (2013) Oxalate nephropathy and intravenous vitamin C. Am J Kidney Dis 61:1032–1035CrossRefPubMed
64.
Zurück zum Zitat Rathi S, Kern W, Lau K (2007) Vitamin C-induced hyperoxaluria causing reversible tubulointerstitial nephritis and chronic renal failure: a case report. J Med Case Rep 1:155CrossRefPubMedPubMedCentral Rathi S, Kern W, Lau K (2007) Vitamin C-induced hyperoxaluria causing reversible tubulointerstitial nephritis and chronic renal failure: a case report. J Med Case Rep 1:155CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat Wong K, Thomson C, Bailey RR, McDiarmid S, Gardner J (1994) Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust N Z J Med 24:410–411CrossRefPubMed Wong K, Thomson C, Bailey RR, McDiarmid S, Gardner J (1994) Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust N Z J Med 24:410–411CrossRefPubMed
66.
Zurück zum Zitat McHugh GJ, Graber ML, Freebairn RC (2008) Fatal vitamin C-associated acute renal failure. Anaesth Intensive Care 36:585–588 McHugh GJ, Graber ML, Freebairn RC (2008) Fatal vitamin C-associated acute renal failure. Anaesth Intensive Care 36:585–588
67.
Zurück zum Zitat Gurm H, Sheta MA, Nivera N, Tunkel A (2012) Vitamin C-induced oxalate nephropathy: a case report. J Community Hosp Intern Med Perspect 2:17718 Gurm H, Sheta MA, Nivera N, Tunkel A (2012) Vitamin C-induced oxalate nephropathy: a case report. J Community Hosp Intern Med Perspect 2:17718
Metadaten
Titel
Ascorbic acid intake and oxalate synthesis
verfasst von
John Knight
Kumudu Madduma-Liyanage
James A. Mobley
Dean G. Assimos
Ross P. Holmes
Publikationsdatum
22.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 4/2016
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-016-0868-7

Weitere Artikel der Ausgabe 4/2016

Urolithiasis 4/2016 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.